臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jia horng kao"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 286-310 / 1180 (共48頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-04T06:12:29Z	Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease	Wang C.-C.; Lin S.-K.; Tseng Y.-F.; Hsu C.-S.; Tseng T.-C.; Lin H.H.; Wang L.-Y.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:29Z	Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels	Tseng T.-C.; Liu C.-J.; Wang C.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:29Z	Prevention of hepatocellular carcinoma in hepatitis B virus infection	Lim S.G.; Mohammed R.; Yuen M.-F.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:28Z	Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C	Hsieh T.-H.; Tseng T.-C.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Hsieh H.-L.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:28Z	Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection	Hsu C.-S.; Liu C.-H.; Liu C.-J.; Wang C.-C.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:28Z	Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients	Chu C.-H.; Yang A.-M.; JIA-HORNG KAO; Liu C.-Y.; Chang W.-H.; Yang W.-S.
臺大學術典藏	2021-09-04T06:12:27Z	High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection	Liu C.-J.; Chen P.-J.; Lai M.-Y.; Liu C.-H.; Chen C.-L.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:27Z	Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy	Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:27Z	Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses	Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D.
臺大學術典藏	2021-09-04T06:12:26Z	Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy	Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:26Z	Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B	Liu C.-J.; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:25Z	Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy	Tseng T.-C.; Liu C.-J.; Hsieh S.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:25Z	IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients	Chuang J.Y.; Yang S.S.; Lu Y.T.; Hsieh Y.Y.; Chen C.Y.; Chang S.C.; Chang C.S.; Yeh H.Z.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	Telaprevir for chronic HCV infection	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	Esomeprazole for asthma [7]	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	HBV genotypes and chronicification of acute hepatitis B: More questions than answers	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	Capsule endoscopy versus colonoscopy	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis	Tong M.J.; Hsien C.; Song J.J.; JIA-HORNG KAO; Sun H.-E.; Hsu L.; Han S.-H.; Durazo F.A.; Saab S.; Blatt L.M.
臺大學術典藏	2021-09-04T06:12:23Z	Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box	Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:23Z	Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease	Hsu C.-S.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:23Z	Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:22Z	Outcomes of HCV treatment: Who does well and who does not?	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:22Z	Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection	Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:22Z	Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients	Hsu C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:22Z	Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link	Wang C.-C.; JIA-HORNG KAO

顯示項目 286-310 / 1180 (共48頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51513166 線上人數 : 1216 教育部委託研究計畫計畫執行:國立臺灣大學圖書館